zx-101a
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 18, 2020 (NCT04504708)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05258266 | Phase 1/Phase 2 (Phase 2) | Mar 9, 2022 | Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
| NCT05269940 | Phase 1/Phase 2 (Phase 2) | Jan 27, 2022 | Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
| NCT04504708 | Phase 1/Phase 2 (Phase 2) | Sep 18, 2020 | Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hangzhou Zenshine Pharmaceuticals Co., Ltd. | For profit | 3 | 3 | 1 | 2020 |
1 organizations
Page 1 / 1